Harish Vasudevan, MD, PhD

Assistant Professor in Res
Radiation Oncology
[email protected]
+1 415 353-7175
Research Description: 

I am a physician scientist in the Departments of Radiation Oncology and Neurological Surgery. My clinical expertise is providing radiotherapy for children and adults with nervous system cancers. My scientific focus is understanding oncogenic growth factor signaling through receptor tyrosine kinases and the Ras signaling pathway with an emphasis on neurofibromatosis and nervous system tumors to identify better treatments for patients.

Primary Thematic Area: 
Cancer Biology & Cell Signaling
Secondary Thematic Area: 
Human Genetics
Research Summary: 
The Vasudevan Laboratory studies growth factor signaling through receptor tyrosine kinases and the Ras signaling pathway in development and cancer with an emphasis on neurofibromatosis.

Websites

Featured Publications: 

Genetic Events and Signaling Mechanisms Underlying Schwann Cell Fate in Development and Cancer.

Neurosurgery

Vasudevan HN, Lucas CG, Villanueva-Meyer JE, Theodosopoulos PV, Raleigh DR

Histopathologic findings in malignant peripheral nerve sheath tumor predict response to radiotherapy and overall survival.

Neuro-oncology advances

Lucas CG, Vasudevan HN, Chen WC, Magill ST, Braunstein SE, Jacques L, Dahiya S, Rodriguez FJ, Horvai AE, Perry A, Pekmezci M, Raleigh DR

Comprehensive Molecular Profiling Identifies FOXM1 as a Key Transcription Factor for Meningioma Proliferation.

Cell reports

Vasudevan HN, Braunstein SE, Phillips JJ, Pekmezci M, Tomlin BA, Wu A, Reis GF, Magill ST, Zhang J, Feng FY, Nicholaides T, Chang SM, Sneed PK, McDermott MW, Berger MS, Perry A, Raleigh DR